SPRY- Ars Pharmaceuticals, Inc.

Name: Ars Pharmaceuticals, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Ars Pharmaceuticals, Inc. (SPRY) has 17 insiders with recent SEC Form 4 filings, including 9 buys and 9 sells. SPRY is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
10%	Flynn James E	4.89M	$51.37M	-
Dir	Shah Pratik	4.47M	$47.03M	-
Other	Tanimoto Sarina	240.0K	$2.52M	-
Other	Chakma Justin	240.0K	$2.52M	-
CEO	Lowenthal Richard E	240.0K	$2.52M	-

Activity

Buys and sells only

Transactions

10 filings · page 10

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Jul 7, 2023	Shawver Laura56	Director	Sale+OE	8,858	$6.36	$56,372.31	-4.0%	-34.9%	+48.5%
Jul 6, 2023	Shawver Laura56	Director	Sale+OE	91,142	$6.48	$590,453.30	-12.6%	-37.8%	+41.5%
Jun 2, 2023	Shawver Laura56	Director	Sale+OE	100,000	$6.84	$684,041.15	-19.2%	-2.1%	+22.7%
May 9, 2023	Shawver Laura56	Director	Sale+OE	143,896	$5.42	$780,578.68	-18.6%	+34.1%	+75.9%
Nov 29, 2022	Scott Kathleen D.64	Chief Financial Officer	Buy	8,250	$6.24	$51,506.40	New	+40.7%	-20.5%
Nov 15, 2021	Root Jonathan D	Director	Buy	2,364	$15.25	$36,048.40	+675.4%	-51.2%	-25.2%
Dec 8, 2020	Thompson Peter A.65	Director, 10% Owner	Buy	1,190,477	$21.00	$25,000,017.00	+442.0%	-	-
Dec 8, 2020	Presidio Management Group Xii, L.l.c.	10% Owner	Buy	47,619	$21.00	$999,999.00	New	-	-
Dec 8, 2020	Root Jonathan D	Director	Buy	95,238	$21.00	$1,999,998.00	New	-	-
Dec 8, 2020	Orbimed Advisors LLC67	Director, 10% Owner	Buy	1,190,477	$21.00	$25,000,017.00	+442.0%	-	-

← PrevPage 10Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC